Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31558) 31558
Newsletter (1536) 1536
Newspaper Article (545) 545
Magazine Article (249) 249
Book Chapter (226) 226
Government Document (84) 84
Dissertation (69) 69
Conference Proceeding (47) 47
Publication (42) 42
Book / eBook (18) 18
Web Resource (17) 17
Reference (9) 9
Transcript (6) 6
Journal / eJournal (3) 3
Paper (2) 2
Trade Publication Article (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26491) 26491
male (25690) 25690
science & technology (21283) 21283
life sciences & biomedicine (20413) 20413
prostate cancer (17599) 17599
prostate-specific antigen - blood (17034) 17034
aged (14238) 14238
middle aged (13891) 13891
prostate-specific antigen (13135) 13135
prostatic neoplasms - pathology (10280) 10280
urology & nephrology (9008) 9008
prostatic neoplasms - blood (8668) 8668
biological and medical sciences (8510) 8510
medical sciences (8184) 8184
prostatic neoplasms - diagnosis (7579) 7579
oncology (6826) 6826
nephrology. urinary tract diseases (5986) 5986
cancer (5802) 5802
urinary tract. prostate gland (5544) 5544
aged, 80 and over (5487) 5487
tumors of the urinary system (5465) 5465
prostate (4923) 4923
prostatic neoplasms - surgery (4651) 4651
tumors (4419) 4419
adult (4145) 4145
prostatectomy (4110) 4110
abridged index medicus (4069) 4069
research (3977) 3977
prognosis (3712) 3712
neoplasm staging (3711) 3711
biopsy (3566) 3566
diagnosis (3404) 3404
retrospective studies (3327) 3327
treatment outcome (3302) 3302
prostate - pathology (3216) 3216
care and treatment (3200) 3200
antigens (3117) 3117
risk factors (3040) 3040
biomarkers, tumor - blood (3003) 3003
urology (2941) 2941
prostatic neoplasms (2887) 2887
prostatic neoplasms - drug therapy (2841) 2841
prostatic neoplasms - therapy (2816) 2816
prostatic neoplasms - mortality (2693) 2693
prostatic neoplasms - radiotherapy (2681) 2681
follow-up studies (2585) 2585
prostate-specific antigen - analysis (2565) 2565
sensitivity and specificity (2502) 2502
gynecology. andrology. obstetrics (2501) 2501
predictive value of tests (2455) 2455
analysis (2449) 2449
male genital diseases (2343) 2343
prostate-specific antigen - metabolism (2210) 2210
health aspects (2144) 2144
time factors (2068) 2068
prostatic neoplasms - metabolism (1987) 1987
prospective studies (1970) 1970
oncology, experimental (1947) 1947
prostate specific antigen (1917) 1917
disease-free survival (1787) 1787
disease progression (1738) 1738
neoplasm grading (1714) 1714
surgery (1686) 1686
prostatic neoplasms - epidemiology (1661) 1661
radiotherapy (1625) 1625
metastasis (1534) 1534
radiology, nuclear medicine & medical imaging (1520) 1520
prostatic neoplasms - genetics (1506) 1506
medicine, general & internal (1494) 1494
general & internal medicine (1491) 1491
psa (1471) 1471
prostatic neoplasms - diagnostic imaging (1444) 1444
prostatectomy - methods (1427) 1427
animals (1411) 1411
risk assessment (1370) 1370
androgen antagonists - therapeutic use (1362) 1362
adenocarcinoma - pathology (1357) 1357
prostatic neoplasms - immunology (1331) 1331
female (1324) 1324
multivariate analysis (1298) 1298
endocrinology & metabolism (1235) 1235
patients (1235) 1235
mass screening (1212) 1212
immunohistochemistry (1200) 1200
prostatic neoplasms - prevention & control (1167) 1167
age factors (1154) 1154
medicine & public health (1128) 1128
usage (1115) 1115
survival rate (1092) 1092
cohort studies (1084) 1084
survival analysis (1066) 1066
prostate-specific antigen - genetics (1047) 1047
adenocarcinoma - blood (1045) 1045
urologic and male genital diseases (991) 991
reproducibility of results (978) 978
physical sciences (963) 963
magnetic resonance imaging (956) 956
radical prostatectomy (955) 955
biopsy, needle (954) 954
cell line, tumor (949) 949
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32434) 32434
Japanese (604) 604
German (524) 524
French (487) 487
Spanish (450) 450
Chinese (277) 277
Portuguese (216) 216
Russian (194) 194
Italian (114) 114
Turkish (46) 46
Dutch (39) 39
Norwegian (34) 34
Hungarian (28) 28
Swedish (28) 28
Danish (22) 22
Polish (19) 19
Korean (17) 17
Czech (14) 14
Serbian (12) 12
Hebrew (10) 10
Croatian (8) 8
Persian (8) 8
Slovak (8) 8
Finnish (7) 7
Lithuanian (6) 6
Romanian (5) 5
Bulgarian (4) 4
Greek (2) 2
Ukrainian (2) 2
Estonian (1) 1
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
by Perera, Marlon and Papa, Nathan and Roberts, Matthew and Williams, Michael and Udovicich, Cristian and Vela, Ian and Christidis, Daniel and Bolton, Damien and Hofman, Michael S and Lawrentschuk, Nathan and Murphy, Declan G
European urology, ISSN 0302-2838, 04/2020, Volume 77, Issue 4, pp. 403 - 417
Sensitivity | Prostate-specific antigen | Imaging | Prostate-specific membrane antigen | Biochemical recurrence | Prostate cancer | Positron emission tomography | Metastases | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
by Catalona, William J and Partin, Alan W and Sanda, Martin G and Wei, John T and Klee, George G and Bangma, Chris H and Slawin, Kevin M and Marks, Leonard S and Loeb, Stacy and Broyles, Dennis L and Shin, Sanghyuk S and Cruz, Amabelle B and Chan, Daniel W and Sokoll, Lori J and Roberts, William L and van Schaik, Ron H.N and Mizrahi, Isaac A
The Journal of urology, ISSN 0022-5347, 2011, Volume 185, Issue 5, pp. 1650 - 1655
Urology | prostate specific antigen | diagnosis | prostate | mass screening | prostatic neoplasms | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Predictive Value of Tests | Prospective Studies | Age Factors | Double-Blind Method | Area Under Curve | Humans | Middle Aged | Male | Prostatic Neoplasms - diagnosis | Chi-Square Distribution | Case-Control Studies | Prostate-Specific Antigen - blood | Biomarkers, Tumor - blood | Regression Analysis | Mass Screening | Biopsy | Sensitivity and Specificity | Prostatic Neoplasms - blood | Aged | Medical colleges | Prostate-specific antigen | Diagnosis | Medical screening | Prostate cancer | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Prostate-Specific Antigen–Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force
by Fenton, Joshua J and Weyrich, Meghan S and Durbin, Shauna and Liu, Yu and Bang, Heejung and Melnikow, Joy
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2018, Volume 319, Issue 18, pp. 1914 - 1931
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Early Detection of Cancer - standards | Age Factors | Early Detection of Cancer - methods | Medical Overuse | Humans | Middle Aged | Risk Factors | Male | Prostatic Neoplasms - diagnosis | False Positive Reactions | Biopsy - adverse effects | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Watchful Waiting | Aged | Practice Guidelines as Topic | Treatment outcome | Usage | Diagnosis | Prostate-specific antigen | Prostate cancer | Analysis | Pollution control | Radiation | Clinical trials | Systematic review | Risk factors | Metastases | Randomization | Mathematical analysis | Antigens | Medical research | Calculators | Complications | Medical treatment | Mortality | Health risks | Risk reduction | Erectile dysfunction | Radiation therapy | Medical screening | Disease control | Contamination | Urinary incontinence | Screening | Surveillance | Biopsy | Men | Risk management | Prostate | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
by Thompson, Ian M and Pauler, Donna K and Goodman, Phyllis J and Tangen, Catherine M and Lucia, M. Scott and Parnes, Howard L and Minasian, Lori M and Ford, Leslie G and Lippman, Scott M and Crawford, E. David and Crowley, John J and Coltman, Charles A
The New England journal of medicine, ISSN 0028-4793, 05/2004, Volume 350, Issue 22, pp. 2239 - 2246
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Prostatic Neoplasms - pathology | Prevalence | Humans | Middle Aged | Male | Risk | Prostate-Specific Antigen - blood | Prostatic Neoplasms - epidemiology | Prostate - pathology | Biopsy | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Prostatic Neoplasms - blood | Aged | Finasteride - therapeutic use | Prostatic Neoplasms - prevention & control | Clinical trials | Medical diagnosis | Prostate cancer | Men | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text A comparative performance analysis of total prostate‐specific antigen, percentage free prostate‐specific antigen, prostate‐specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
by Auprich, Marco and Augustin, Herbert and Budäus, Lars and Kluth, Luis and Mannweiler, Sebastian and Shariat, Shahrokh F and Fisch, Margit and Graefen, Markus and Pummer, Karl and Chun, Felix K.‐H
BJU international, ISSN 1464-4096, 06/2012, Volume 109, Issue 11, pp. 1627 - 1635
prostate cancer | urinary prostate cancer gene 3 | percentage free PSA | PSA velocity | total PSA | repeat prostate biopsy | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Predictive Value of Tests | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Digital Rectal Examination | Humans | Middle Aged | RNA, Messenger - genetics | Risk Factors | Male | RNA, Messenger - metabolism | Antigens, Neoplasm - urine | Prostate-Specific Antigen - blood | ROC Curve | Aged | Biopsy, Needle | Cohort Studies | Biopsy | Prostate cancer | Accuracy | Index Medicus | Neoplasia | Risk factors | Rectum | prostate-specific antigen
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Screening for Prostate Cancer With the Prostate-Specific Antigen Test: A Review of Current Evidence
by Hayes, Julia H and Barry, Michael J
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2014, Volume 311, Issue 11, pp. 1143 - 1149
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Prevention and actions | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Models, Theoretical | Early Detection of Cancer | Humans | Middle Aged | Male | Reference Values | Prostatic Neoplasms - diagnosis | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Randomized Controlled Trials as Topic | Mass Screening | Aged, 80 and over | Prostatic Neoplasms - blood | Aged | Usage | Diagnosis | Research | Prostate cancer | Immune system | Testing | Clinical trials | Mens health | Medical screening | Mortality | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text 3D label-free prostate specific antigen (PSA) immunosensor based on graphene–gold composites
by Jang, Hee Dong and Kim, Sun Kyung and Chang, Hankwon and Choi, Jeong-Woo
Biosensors & bioelectronics, ISSN 0956-5663, 01/2015, Volume 63, pp. 546 - 551
Aerosol spray pyrolysis | Crumpled graphene–gold composite | Label-free immunosensor | Prostate specific antigen (PSA) | Crumpled graphene-gold composite | Physical Sciences | Chemistry | Nanoscience & Nanotechnology | Life Sciences & Biomedicine | Electrochemistry | Science & Technology - Other Topics | Biophysics | Chemistry, Analytical | Biotechnology & Applied Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Biotechnology | Biological and medical sciences | Biosensors | Methods. Procedures. Technologies | Various methods and equipments | Gold - chemistry | Immunoassay - instrumentation | Nanocomposites - chemistry | Antibodies - chemistry | Metal Nanoparticles - chemistry | Oxides - chemistry | Equipment Design | Prostate-Specific Antigen - analysis | Conductometry - instrumentation | Staining and Labeling | Antibodies - immunology | Biosensing Techniques - instrumentation | Nanocomposites - ultrastructure | Prostate-Specific Antigen - immunology | Graphite - chemistry | Prostate-Specific Antigen - chemistry | Equipment Failure Analysis | Pyrolysis | Composite materials industry | Graphene | Prostate-specific antigen | Graphite | Prostate cancer | Electric properties | Index Medicus | Electrodes | Antigens | Gold | Immunosensors | Prostate | Three dimensional
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Low Detectable Prostate Specific Antigen after Radical Prostatectomy—Treat or Watch?
by Koulikov, Dmitry and Mohler, Maura C and Mehedint, Diana C and Attwood, Kristopher and Wilding, Gregory E and Mohler, James L
The Journal of urology, ISSN 0022-5347, 2014, Volume 192, Issue 5, pp. 1390 - 1396
Urology | prostatectomy | prostate | neoplasm recurrence | prognosis | local | prostate-specific antigen | prostatectomy; prostate-specific antigen | neoplasm recurrence, local | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Survival Rate - trends | Follow-Up Studies | Prostatic Neoplasms - surgery | Humans | Middle Aged | Postoperative Period | Male | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Incidence | Biomarkers, Tumor - blood | Disease-Free Survival | Time Factors | Prostatic Neoplasms - blood | Adult | Prostatectomy | Aged | Neoplasm Recurrence, Local - epidemiology | Retrospective Studies | New York - epidemiology | Prostate-specific antigen | Prostate cancer | Surgery | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights